EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Adipokines and Vascular Modulators in CKM: Emerging Biomarkers as Diagnostic and Therapeutic Targets

Cezara-Andreea Gerdanovics iD, Șoimița-Mihaela Suciu, Olga-Hilda Orășan iD, Ioana Para, Vladiana-Romina Turi iD, Mircea-Vasile Milaciu, Mirela-Georgiana Perne iD, Lorena Ciumărnean, Nicoleta-Valentina Leach, Teodora-Gabriela Alexescu iD, Vlad-Dumitru Brata iD, Alexandru Gerdanovics iD und 1 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262211083 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Cezara-Andreea Gerdanovics und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, 4th Medical Discipline, "Iuliu Hațieganu" University of Medicine and Pharmacy, Republicii Street, No. 18, 400015 Clu…. Hauptthemen laut MEDLINE: Biomarkers, Adipokines, Metabolic Syndrome, Cardiovascular Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardio-kidney-metabolic (CKM) syndrome represents an integrated clinical and molecular continuum encompassing metabolic dysfunction, cardiovascular disease and chronic kidney disease. This multidimensional disorder arises from interdependent biological pathways that extend beyond conventional risk factors. Emerging evidence highlights a group of adipokines and vascular modulators—including retinol-binding protein 4 (RBP4), lipocalin 2 (LCN2), apolipoprotein M (ApoM), Klotho and matrix Gla protein (MGP)—emerging molecular modulators with potential involvement in CKM pathophysiology. Pro-inflammatory adipokines such as RBP4 and LCN2 contribute to insulin resistance, oxidative stress and endothelial dysfunction. In contrast, protective molecules including ApoM and Klotho preserve nitric oxide bioavailability, lipid metabolism and antioxidant defense. MGP modulates vascular calcification and adipose remodeling, with its inactive form (dp-ucMGP) linked to vascular stiffness and renal decline. The combined dysregulation of these molecules sustains cycles of inflammation, oxidative stress and tissue remodeling that drive CKM progression. Collectively, current data support their dual role as biomarkers and therapeutic targets. Nonetheless, clinical translation remains limited, emphasizing the need for standardized assays, longitudinal validation, and integrative multimarker approaches within precision medicine frameworks for CKM syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersAdipokinesMetabolic SyndromeCardiovascular DiseasesRenal Insufficiency, ChronicHumansAnimalsOxidative StressLipocalin-2

Stichwörter der Autor:innen

Klothoadipokinesapolipoprotein Mbiomarkerscardio-kidney-metabolic syndromelipocalin 2matrix Gla proteinoxidative stressretinol-binding protein 4vascular calcification

Substanzen

BiomarkersAdipokinesLipocalin-2

Autor:innen und Institutionen

  • Department of Internal Medicine, 4th Medical Discipline, "Iuliu Hațieganu" University of Medicine and Pharmacy, Republicii Street, No. 18, 400015 Cluj-Napoca, Romania.
  • Department of Physiology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 1-3 Clinicilor Street, 400006 Cluj-Napoca, Romania.
  • University Clinic of Internal Medicine IV, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy of Timisoara, 2 Eftimie Murgu Square, 300041 Timisoara, Romania.
  • Department 2, Faculty of Nursing and Health Sciences, "Iuliu Hațieganu" University of Medicine and Pharmacy, Republicii Street, No. 18, 400015 Cluj-Napoca, Romania.
  • Department of Gastroenterology, Regional Institute of Gastroenterology and Hepatology "Prof. Dr. Octavian Fodor", 400394 Cluj-Napoca, Romania.
  • Department of Pathophysiology, "Iuliu Haţieganu" University of Medicine and Pharmacy, Victor Babeş Street, No. 2-4, 400012 Cluj-Napoca, Romania.

ORCID-Profile: Cezara-Andreea Gerdanovics, Olga-Hilda Orășan, Vladiana-Romina Turi, Mirela-Georgiana Perne, Teodora-Gabriela Alexescu, Vlad-Dumitru Brata, Alexandru Gerdanovics, Angela Cozma

Zitieren

APA

Gerdanovics, C. A., Suciu, Ș. M., Orășan, O. H., Para, I., Turi, V. R., Milaciu, M. V., Perne, M. G., Ciumărnean, L., Leach, N. V., Alexescu, T. G., Brata, V. D., Gerdanovics, A., & Cozma, A. (2025). Adipokines and Vascular Modulators in CKM: Emerging Biomarkers as Diagnostic and Therapeutic Targets. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211083

Vancouver

Gerdanovics CA, Suciu ȘM, Orășan OH, Para I, Turi VR, Milaciu MV, et al. Adipokines and Vascular Modulators in CKM: Emerging Biomarkers as Diagnostic and Therapeutic Targets. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262211083

BibTeX
@article{Gerdanovics2025,
  author = {Gerdanovics, Cezara-Andreea and Suciu, Șoimița-Mihaela and Orășan, Olga-Hilda and Para, Ioana and Turi, Vladiana-Romina and Milaciu, Mircea-Vasile and Perne, Mirela-Georgiana and Ciumărnean, Lorena and Leach, Nicoleta-Valentina and Alexescu, Teodora-Gabriela and Brata, Vlad-Dumitru and Gerdanovics, Alexandru and Cozma, Angela},
  title = {Adipokines and Vascular Modulators in CKM: Emerging Biomarkers as Diagnostic and Therapeutic Targets},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262211083}
}
Kostenlos starten →